Introduction
Sustained ventricular tachycardia (VT) in patients with non-ischaemic cardiomyopathy (NICM) is often due to myocardial re-entry and occasionally to triggered activity both associated with the presence of fibrosis. 1, 2 Animal models and human data in end-stage heart failure suggest that the degree of arrhythmogeneity depends on amount and architecture of fibrosis with highest propensity for intermediate degrees and patchy architecture. [3] [4] [5] However, histological data from patients with NICM and sustained monomorphic VT (MVT) is lacking. Electroanatomical bipolar voltage (BV) and unipolar voltage (UV) mapping is considered an invasive reference method to detect fibrosis. 6 Different endocardial BV and UV cut-off values for detecting fibrosis have been proposed. [7] [8] [9] It has been suggested that the presence of a viable sub-endocardial layer overlying fibrosis may prevent its detection by BV mapping using the currently uniformly applied BV cut-off of 1.5 mV. 8, 9 Unipolar voltage mapping is considered to have a larger field of view and thus superior in detecting mid-wall and sub-epicardial fibrosis. [9] [10] [11] However, neither the currently used cut-off values for detecting fibrosis in NICM, nor the 'field of view' of UV or BV have been validated. To date, the only histological validation of electroanatomical voltage mapping (EAVM) for scar detection arises from animal infarct models. 12 Infarct scars, with a transmural pattern and compact fibrosis interspersed with viable myocardial bundles, may be substantially different from NICM scars. 4, 13 Animal models mimicking NICM scar patterns are lacking.
The purpose of this study was two-fold: (i) to evaluate the location, pattern, architecture, and amount of fibrosis in patients with NICM and sustained VT and (ii) to evaluate the performance of EAVM to detect fibrosis by ex vivo registration of EAVM data with whole heart histology.
Methods

Patients and controls
Non-ischaemic cardiomyopathy patients who underwent detailed EAVM and ablation for MVT and either died or received heart transplantation after the procedure were included (Supplementary material online, methods). All patients were treated according to our standard clinical protocol and provided informed consent for mapping and ablation. All patients and/or next of kin provided informed consent for post-mortem analysis.
Transmural biopsies (TB) from seven age-matched hearts, in which cardiac pathology was excluded by an experienced pathologist, served as controls.
Electroanatomical mapping and ablation
High-density EAVM was performed during sinus rhythm or right ventricular pacing using a 3.5 mm irrigated-tip catheter (1 mm ring electrode, 2 mm inter-electrode spacing; NaviStar Thermocool, Biosense Webster Inc., CA, USA) and the CARTO V R system ( Figure 1A ) (Supplementary material online, methods). 7, 11, 14, 15 Ex vivo image integration Three-dimensional meshes were created from 5 mm thick slices of the fixed heart, imported into CARTO V R , and merged with EAVM data ( Figure 1B and C) (Supplementary material online, methods). 9 
Histological analysis
Transmural biopsies with a width of 5 mm (7 lm thick) were taken from left ventricular (LV) sites corresponding to non-ablation EAVM sites and stained with Picrosirius Red ( Figure 1D ) (Supplementary material online, methods). In all patients, TB were taken from seven locations: the anterior-septal, lateral and inferior wall at the mid, and basal level and the apex. Transmural biopsies with signs of acute or old ablation lesions were excluded. Transmural biopsies were systematically assessed on the following parameters:
Location
The fibrotic involvement of the seven LV segments was macroscopically assessed in the stained TB to determine the location of fibrosis.
Pattern
According to the dominant site of fibrosis throughout the myocardium, five patterns were defined by visual assessment: minimal interstitial fibrosis (not restricted to one area of the biopsy), sub-endocardial, mid-wall, sub-epicardial, and transmural fibrosis ( Figure 2A ).
Architecture
The dominant architecture of fibrosis present within a TB was defined as: interstitial, patchy, diffuse, compact, or a combination thereof (for definitions and examples see Figure 2B ). Pattern and architecture of fibrosis in a random selection of TB were reviewed by a co-author (C.B.) to assess inter-observer agreement (Supplementary material online, methods).
Amount
Wall thickness (WT) of each TB was measured. Custom pixel-by-pixel software calculated the percentage of fibrosis and the amount of viable myocardium (mm 2 ) within each TB (Supplementary material online, methods and Figure S1 ). The area of viable myocardium was used as a surrogate for the volume of viable myocardium at that location (Supplementary material online, methods and Figure S2 ). From the control biopsies, 7 lm sections were taken and the percentage fibrosis calculated.
Statistical analysis
Normally distributed data was reported as mean ± standard deviation; not normally distributed data as median and interquartile range (IQR). Categorical data was expressed as percentages or frequencies. Continuous variables were compared using (multivariable) linear regression analysis in a model that allowed for intragroup correlation. Statistical analysis was performed using IBM SPSS version 23 (SPSS Inc., Chicago, IL, USA) or STATA Statistical Software (StataCorp, College Station, TX, USA), version 14.
Results
Patients
Electroanatomical voltage mapping data and whole heart histology of eight male NICM patients with MVT [median age 63 (IQR 58-68) years] were analysed ( Table 1) . Seven patients died and one patient was successfully transplanted a median of 25 (IQR 6-217) days after EAVM. Cause of death was sepsis (n = 2) 28 and 497 days after ablation, cardiogenic shock, and/or severe vasoplegia with multi-organ failure (n = 4) within 5 days of ablation and in one case cardiogenic shock 21 days after ablation without VT or obvious luxation. Table S1 ). In two patients, a second mapping procedure was performed within 29 days and data from both procedures were included.
Controls
Control tissue for histology was obtained from seven age-matched hearts [five male, median age 65 (IQR 59-67) years]. From each heart, four LV TB were taken from the anterior, lateral, inferior, and septal walls. The amount of fibrosis in each biopsy was assessed, with a median of 6.5% (IQR 4.9-9.3) fibrosis. Based on the 95th percentile, 21% was defined as the upper limit of normal quantity of fibrosis for this age group.
Ex vivo integration
Integration of the ex vivo 3D meshes with the in vivo mapping data was accurate based on good agreement between macroscopically or histologically identified ablation lesion and ablation sites on EAVM ( Figure 1D) . A median of 138 (IQR 98-198) endocardial and 172 (IQR 142-338) epicardial mapping points per patient were included for analysis.
Histology of non-ischaemic cardiomyopathy
In total, 507 TB [56 (IQR 34-96) TB per patient] were taken; 277 corresponding to endocardial non-ablation EAVM sites (endocardial TB) and 230 corresponding to epicardial non-ablation EAVM sites (epicardial TB) (Supplementary material online, Table S2 ). 
Location
On histological analysis, all NICM hearts showed pathological amounts of fibrosis. The basal-anterior and basal-septal segments were most frequently affected, followed by mid-anterior and apicalanteroseptal involvement. Unipolar voltage mapping overestimated and BV mapping underestimated involvement as derived from histology (Supplementary material online, Table S2 ).
Pattern
Of all TB, 32 (6%) were classified as having minimal interstitial fibrosis on visual assessment, 153 (30%) were classified as dominant subendocardial fibrosis, 96 (19%) as mid-wall, 83 (17%) as sub-epicardial, and 143 (28%) as transmural fibrosis.
Architecture A patchy architecture was the most common dominant architecture and occurred in 277 (55%) of TB, followed by diffuse in 171 (34%), and interstitial in 45 (9%) (Supplementary material online, Table S3 ). Of interest, compact fibrosis was the dominant architecture in only 14 (3%) TB and never extended transmurally. In 457 (90%) TB, a combination of two or three architectures was observed. The most common combination of fibrosis architecture was patchy and interstitial (44% of all TB). 
Amount
Voltages and corresponding histology
Voltages and histological parameters of TB with normal and abnormal amounts of fibrosis are given in Table 2 .
Voltages and ex vivo wall thickness
Within TB with normal amounts of fibrosis, there was a linear relationship between WT and endocardial UV ( Figure 3A) . For every millimetre increase in ex vivo WT the UV increased by 0.28 mV (P = 0.010). Of interest, the same linear relationship was observed between BV and WT: for every millimetre increase in ex vivo WT the BV increased by 0.23 mV (P = 0.009).
Voltages and amount of viable myocardium
In all TB, a linear relationship between amount of viable myocardium and UV generated was observed. A 1 mm 2 increase in viable myocardium resulted in a 0.09 mV (P = 0.002) increase in endocardial UV ( Figure 3B ) and a 0.08mV (P = 0.016) increase in epicardial UV. Notably, there was a comparable linear relationship between amount of viable myocardium and the endocardial BV generated. A 1 mm 2 increase in amount of viable myocardium resulted in a 0.06 mV (P = 0.001) increase in endocardial BV. A single cut-off to detect an amount of viable myocardium performed poorly irrespective of the amount of viable myocardium that was considered relevant (Supplementary material online, results).
Field of view of unipolar voltage and bipolar voltage
It has previously been suggested that BV is limited by a field of view. 7, 16 To test the impact of fibrosis remote from the endocardial surface, the relationship between amount of viable myocardium within TB and the endocardial voltages generated was analysed within a sub-selection of TB which had a normal amount of fibrosis in the 4 mm sub-endocardium ( Figure 3C ). Both UV and BV were impacted by changes in the amount of viable myocardium occurring at distances of >4 mm from the endocardial surface. A 1 mm 2 increase in the amount of viable myocardium beyond the 4 mm subendocardial rim resulted in a UV increase of 0.09 mV (P = 0.012) and BV increase of 0.05 mV (P = 0.046).
Voltages, ex vivo wall thickness, and amount of fibrosis
Multiple linear regression was performed to predict the amount of fibrosis based on the voltage and WT measured. Both UV and BV can be used to predict the amount of fibrosis when ex vivo WT is known (P < _ 0.017). An equation taking into account both WT and the amount of fibrosis present was generated (Figure 4) . 
Main findings
This study is the first to provide detailed histological data on fibrosis in NICM patients with sustained MVT and to couple EAVM data with the true gold standard for fibrosis identification-histology. The fibrosis pattern is highly variable and not restricted to the mid-wall and sub-epicardium. The fibrosis architecture is most often patchy or diffuse and a combination of more than one architecture occurs frequently. The compact fibrosis architecture observed in infarct scar is very rare in NICM and never reaches transmurality. Unipolar voltages, and contrary to most commonly held beliefs, BV, are affected by WT. Additionally, the amount of fibrosis affects UV and BV. We demonstrate a linear relationship between the amount of viable myocardium and both the UV and BV amplitudes (Take home figure) . In this patient population, neither BV nor UV is restricted by a 'field of view'.
Our findings have important clinical implications. Firstly, a single BV or UV cut-off to detect fibrosis, as currently applied in practice, cannot be valid considering the range of observed WT. Secondly, as the 
Fibrosis in non-ischaemic cardiomyopathy
The only histological data in patients with NICM come from dated autopsy studies in patients with terminal heart failure. [17] [18] [19] These studies showed a dominant sub-endocardial fibrosis pattern which may be attributed to pressure overload or ischaemia. In end-stage heart failure patients a variable degree of interstitial fibrosis was seen at sites of induced focal, non-sustained, polymorphic VTs.
20
Late gadolinium-enhanced cardiac magnetic resonance (LGE-CMR) is the imaging reference method for the non-invasive detection of regional fibrosis in NICM. 21 A study including 63 unselected patients with dilated cardiomyopathy reported no LGE in the majority of patients (59%), sub-endocardial LGE in 13% (attributed to ischaemia), and mid-wall or sub-epicardial LGE in 28% typically involving the basal and mid-LV 22 . The presence and extent of particularly mid-wall fibrosis has been associated with inducible VT 23 and with mortality and (aborted) sudden cardiac death in a recent cohort of 472 NICM patients. 24 Our study is the first to specifically describe the fibrosis pattern and architecture in patients with NICM and sustained MVT. In contrast to what is reported in imaging studies, the mid-wall or subepicardial fibrosis pattern was seen in only 36% of TB. A further 30% showed a sub-endocardial pattern and a transmural pattern was seen in 28%. Of importance, only 3% of TB showed compact fibrosis with the density of ischaemic scars, and this fibrosis was never transmural. A patchy (55%), followed by a diffuse architecture (34%) was most frequently found.
To date, LGE-CMR to detect and determine scar size has only been histologically validated in an ex vivo animal model for postinfarct scar. 25 Current LGE-CMR methods to detect fibrosis require either bright areas with dense fibrosis or normal reference myocardium. The present study demonstrates that in NICM, areas with compact fibrosis are rare and that 'normal' reference myocardium may contain variable degrees of fibrosis. The comparison of in vivo LGE-CMR data from one patient obtained 133 days before mapping and ablation illustrates the variation in scar size dependent on the applied LGE-CMR method and supports the limitation of LGE-CMR to accurately identify and delineate diffuse fibrosis ( Figure 5 and Supplementary material online, methods).
23,26-28
Voltage mapping in non-ischaemic cardiomyopathy
Voltage mapping is considered the gold standard for the invasive identification of fibrosis. The cut-off values for UV and BV proposed in the literature vary in their absolute value and in the population in which they were derived. Cut-offs UV >8.27 mV and BV >1.5 mV were derived from patients without structural heart disease. However, sampling locations and WT in these young patients were not reported and these cut-offs were poor predictors of normal amounts of fibrosis in our cohort (Supplementary material online, results). Ischaemic cardiomyopathy studies (pig models and humans) have shown that BV <1.5 mV is useful in identifying compact, transmural, thin-walled scars. However, BV <1.5 mV could not detect nontransmural, small sub-epicardial scar, or grey-zone. 26, 29 This was attributed to the smaller field of view of BV, and it has been suggested that cut-offs based on ischaemic scars may not be valid for NICM scars. 8, 9, 30 Linear relationship between wall thickness and unipolar voltage and bipolar voltage amplitude Figures S3 and S4) . 31 As such, myocardial bundles located closer to the catheter contribute more to the amplitude of both UV and BV electrograms than myocardial bundles located further away from the catheter. Additionally, BV is less sensitive to the activity of viable myocardium occurring at distances remote from the catheter tip than UV, leading to the concept of a limited 'field of view'. 7, 16 Of interest, we found a linear relation between WT and electrogram amplitude for both UV and BV. Importantly, for relatively large distances between 10-20 mm, the relationship between WT and amplitude is near linear (Supplementary material online, Figure S5 ), which is in line with the linear relationship we found between BV and UV within the clinically relevant range of WT in our cohort.
Linear relationship between amount of fibrosis and unipolar voltage and bipolar voltage amplitude
Not only the WT, but also the amount of fibrosis, affects the amount of viable myocardium present and thus influences both UV and BV. An increase in fibrosis reduces the amount of viable myocardium resulting in a linear decrease in UV and BV. Our data demonstrated such a linear relationship. Accordingly, it is important to take both these parameters into account when interpreting EAVM data.
'Field of view' of unipolar voltage and bipolar voltage
In this study, we show that both UV and BV are sensitive to histological changes occurring more distantly from the catheter tip. We could demonstrate that endocardial BV is also affected by fibrosis occurring >4 mm from the catheter. Whether BV and UV amplitudes, as well as voltages generated using a catheter with smaller electrodes, provide complementary information on fibrosis location needs further evaluation. Smaller electrodes are likely to reduce far field contamination and may be beneficial for areas with subendocardial involvement but would be potentially less helpful in areas with a mid-wall pattern of fibrosis.
Conclusions
Fibrosis pattern in patients with NICM and VTs are variable with similar prevalence of sub-endocardial, mid-wall/sub-epicardial, and transmural patterns. Patchy and diffuse architectures dominate whereas compact fibrosis is rare. These specific characteristics of fibrosis are likely to impact its accurate delineation by current LGE-CMR methods. Both BV and UV mapping are sensitive not only to the amount of fibrosis but also to myocardial WT. Similarly, both BV and UV mapping are not restricted by a 'field of view'. Accordingly, and of high-clinical importance, a single BV and UV cut-off for detecting the amount and location of fibrosis without considering the local WT and architecture of fibrosis cannot be valid.
This study has taken an important step in this regard, providing an equation for detection of fibrosis based on UV and/or BV and WT. Further study is needed to generate a comprehensive algorithm, appropriate for in vivo, real time, mapping, and imaging.
Limitations
Whilst we have described the fibrosis present in NICM patients with VT, the specific fibrosis needed to sustain VT has not been identified.
This study reported ex vivo WT. Wall thickness measured in formalin-fixed hearts are comparable to the end-systolic WT measured on echocardiography. 32 
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